Clinical Research Directory
Browse clinical research sites, groups, and studies.
Back to Studies
COMPLETED
NCT00186641
PHASE2
High Dose Chemotherapy and Autologous Transplant for Breast Cancer
Sponsor: Stanford University
View on ClinicalTrials.gov
Summary
To determine survival outcomes for patients with chemosensitive brest cancer after treatment with high dose chemotherapy
Official title: High Dose Chemotherapy and Peripheral Blood Progenitor Cell Rescue for Patients With Breast Cancer
Key Details
Gender
All
Age Range
18 Years - 65 Years
Study Type
INTERVENTIONAL
Enrollment
203
Start Date
Not specified
Completion Date
2008-02-08
Last Updated
2026-06-05
Healthy Volunteers
No
Conditions
Interventions
PROCEDURE
high dose chemo and auto hematopoietic cell transplant
Locations (1)
Stanford University Cancer Center
Stanford, California, United States